Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Breakthrough in diabetes treatment! The US FDA approves Ozempic for reducing kidney disease risk in diabetic patients. Learn ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

The 'game changing' weekly injections have helped thousands of people who need to lose weight and improve their health. But it has an unwanted side effect.

Ozempic is a solution for subcutaneous injection that’s approved by the Food and Drug Administration (FDA) to: An interaction occurs when one substance causes another substance to have a ...

“The rapid reduction in subcutaneous fat can accentuate fine lines and wrinkles, making the skin appear more aged.” Ozempic is a formulation of the drug semaglutide, which is used to treat ...

You take Mounjaro and Ozempic the same way. Both drugs are once-a-week subcutaneous (under the skin) injections. You can administer the injection into your stomach, thigh or upper arm, at any time ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.